•  
  •  
 

Corresponding Author

Ahmed Ismail Ali Ismail

Document Type

Original Article

Abstract

Background: Benign lesions called warts can develop on the skin and mucosa. These are among the most prevalent skin conditions, and their severity can vary from a small quantity of annoyance that goes away on its own to a bothersome chronic ailment.

Aim and objectives: To cure plantar warts, this study assesses the safety and effectiveness of intralesional polidocanol sclerotherapy.

Patients and methods: This is a prospective, open-label pilot research involving 80 plantar wart patients. They were chosen from Al-Azhar University Hospitals' Outpatient Dermatology Clinics. In addition to a clinical and dermatological examination, every patient had a thorough history-taking procedure (including age, sex, length of disease, history of drug use, and history of other related diseases) and images of their lesions during the initial and follow-up appointments.

Results: Regarding the response, there were statistically significant differences (P<0.0001) between the analyzed groups. Patients in groups A and B had the highest complete response rates (60%), group C had the lowest (45%), and the control group had the lowest percentage (10%). Patients in the control group had a much higher rate of no response (70%) than those in groups A, B, and C, which were 15%, 10%, and 20%, respectively. Additionally, the response rate in the sclerotherapy groups (A, B, and C) was substantially more significant than in the control group (p<0.05; all), according to the current study.

Conclusion: Because intralesional polidocanol sclerotherapy is easy to use and does not require any additional equipment, it is a cost-effective and safe treatment option for plantar warts.

Keywords

Intralesional polidocanol sclerotherapy; plantar warts; Safety; Efficacy

Subject Area

Dermatology

Download

Share

COinS